Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Axatilimab in Healthy Japanese Male Participants: Results from a Phase 1, Randomized, Double-Blind, Dose-Escalation Study

Haranaka M, et al.

Citation

Clin Drug Investig. 2025 Jun;45(6):327-334.

PMID

40381116